167 related articles for article (PubMed ID: 4370356)
1. Selection of hormone-dependent breast cancers.
Hobbs JR; De Souza I; Salih H; Raggatt P
Br J Surg; 1974 Oct; 61(10):785-6. PubMed ID: 4370356
[No Abstract] [Full Text] [Related]
2. [Hormonal therapy of metastizing breast cancer].
von Werder K
Med Klin; 1976 Feb; 71(8):313-21. PubMed ID: 56699
[No Abstract] [Full Text] [Related]
3. Endocrine manipulation in the treatment of breast cancer.
Segaloff A
Clin Obstet Gynecol; 1975 Jun; 18(2):227-37. PubMed ID: 166781
[No Abstract] [Full Text] [Related]
4. [Estrogen receptors in breast cancers and endocrine therapy].
Maass H; Trams G; Nowakowski H
Strahlentherapie; 1974 Apr; 147(4):381-7. PubMed ID: 4369557
[No Abstract] [Full Text] [Related]
5. [The current status of endocrine therapy in the palliative treatment of the metastasizing breast carcinoma in women].
Nowakowski H
Chirurg; 1968 Jun; 39(6):258-63. PubMed ID: 5697277
[No Abstract] [Full Text] [Related]
6. [Endocrine and cytostatic treatment of metastazing breast carcinoma in the female].
Nowakowski H
Strahlentherapie; 1974 Apr; 147(4):388-400. PubMed ID: 4409449
[No Abstract] [Full Text] [Related]
7. Selecting endocrine therapy for metastatic breast cancer.
McGuire WL
Postgrad Med; 1976 Feb; 59(2):77-80. PubMed ID: 175359
[No Abstract] [Full Text] [Related]
8. Estrogen receptors in hormone-dependent breast cancers.
Jensen EV
Cancer Res; 1975 Nov; 35(11 Pt. 2):3362-4. PubMed ID: 172222
[TBL] [Abstract][Full Text] [Related]
9. [Hormones and tumor therapy: current clinical status and future developments in endocrine therapy of breast cancer].
Szepesi T; Schratter-Sehn AU
Wien Klin Wochenschr; 1982 Sep; 94(17):463-9. PubMed ID: 6760557
[TBL] [Abstract][Full Text] [Related]
10. [Current problems in the therapy of diffuse breast carcinoma].
Di Pietro S
Minerva Radiol; 1968 Oct; 13(10):569-73. PubMed ID: 5734810
[No Abstract] [Full Text] [Related]
11. [Therapeutic problems in hormone-dependent cancer].
Zimel H
Stud Cercet Endocrinol; 1969; 20(2):111-25. PubMed ID: 4898947
[No Abstract] [Full Text] [Related]
12. Proceedings: Clinical value of predictive tests for advanced breast cancer.
Engelsman E
Br J Cancer; 1974 Aug; 30(2):189-90. PubMed ID: 4370884
[TBL] [Abstract][Full Text] [Related]
13. [Possibilities and limitations of endocrine therapy of metastasizing breast cancer].
Nowakowski H
Verh Dtsch Ges Inn Med; 1967; 73():505-18. PubMed ID: 5591802
[No Abstract] [Full Text] [Related]
14. Prediction of breast cancer response to endocrine therapy.
DeSombre ER; Smith S; Block GE; Ferguson DJ; Jensen EV
Cancer Chemother Rep; 1974; 58(4):513-9. PubMed ID: 4369030
[No Abstract] [Full Text] [Related]
15. [Endocrinic management of metastasizing breast carcinoma in the female].
Nowakowski H
Internist (Berl); 1968 Sep; 9(9):380-8. PubMed ID: 4918658
[No Abstract] [Full Text] [Related]
16. [Hormone-therapy of carcinoma of the breast].
Villani C; Mazzon I
Minerva Ginecol; 1981 Jan; 33(1):3-26. PubMed ID: 7017505
[No Abstract] [Full Text] [Related]
17. A multidisciplined approach for the management of metastatic breast cancer.
Oberfield RA; Cady B; Pazianos AG; Salzman FA
Med Clin North Am; 1972 May; 56(3):651-64. PubMed ID: 5034893
[No Abstract] [Full Text] [Related]
18. [Hormone therapy and chemotherapy of metastasizing breast cancer. Experiences of the Basle Oncology Center, 1969-72].
Byland W; Nagel G; Senn HJ
Schweiz Med Wochenschr; 1974 Aug; 104(31):1077-85. PubMed ID: 4445838
[No Abstract] [Full Text] [Related]
19. A new approach for selecting patients with metastatic breast cancer for hypophysectomy.
McGuire WL
Clin Neurosurg; 1974; 21():39-59. PubMed ID: 4371771
[No Abstract] [Full Text] [Related]
20. [Hormone dependence and the basis of hormone therapy in breast cancer].
Martin PM
J Gynecol Obstet Biol Reprod (Paris); 1978 Mar; 7(2):183-99. PubMed ID: 209076
[No Abstract] [Full Text] [Related]
[Next] [New Search]
